Key barriers in adhering to anticoagulation guidelines included uncertainty about its choice, established practices, and the momentum of treatment once initiated.
Medical Device Network on MSN8d
Akura enrols first subject in pulmonary embolism trial of thrombectomy systemAkura Medical has enrolled the first subject in the multi-centre QUADRA-PE trial, which is assessing its flagship Katana thrombectomy system in treating acute pulmonary embolism (PE) patients. TriStar ...
News Medical on MSN5d
Evaluating the safety and efficacy of Tendvia mechanical thrombectomy for acute pulmonary embolismAnnouncing a new article publication for Cardiovascular Innovations and Applications journal. Mechanical thrombectomy is effective and safe for treating pulmonary embolism (PE).
Akura Medical, Inc., a privately held portfolio company of Shifamed LLC that is developing treatments for venous thromboembolis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback